title: Thyroid and adrenal dysfunction in abstinent alcoholic men: locus of disturbance.
abstract: Certain neuroendocrine abnormalities (e.g., blunted plasma adrenocorticotropic hormone [ACTH] response to corticotropin-releasing hormone [CRH] administration and blunted serum TSH response to thyrotropin-releasing hormone [TRH] administration) are common in alcoholic patients. It was the objective of this study to evaluate whether they are centrally mediated: that is, whether they are secondary to increased activity of CRH and/or TRH neurons. We evaluated the nocturnal secretion (2200 hours to 1000 hours, q 15 min) of plasma ACTH, serum cortisol, and serum TSH, and their responses to the combined administration of CRH and TRH, in 28 acutely abstinent alcoholic (age range: 32 to 57 years; mean: 42.4 years) and 19 normal men (age range: 21 to 52 years; mean: 32.1 years). To assess the validity of administering CRH and TRH simultaneously, we gave 10 additional abstinent alcoholic men (age range: 36 to 53 years; mean: 45.8 years), in random order and at least 4 days apart, either CRH, TRH, placebo, or CRH plus TRH. Nocturnal ACTH, cortisol, and TSH secretion, as well as cortisol and TSH responses after CRH plus TRH administration, were similar in alcoholic and normal men. However, ACTH peak responses to CRH plus TRH were reduced in the alcoholic men (p < 0.05). The ACTH, but not cortisol, response was greater after combined CRH plus TRH administration than after CRH alone (p < .002). The blunted ACTH response does not appear to be the result of increased endogenous CRH activity, because all parameters of nocturnal ACTH pulsatility were normal in the alcoholics. It rather appears to be secondary to an intrinsic defect in the CRH responsiveness of the pituitary corticotroph, possibly due to genetic vulnerability or to the toxic effects of prolonged alcohol abuse.
authors.affiliation: Department of Psychiatry, Vanderbilt University Medical Center, Nashville, Tennessee.
authors.forename: P T
authors.initials: PT
authors.lastname: Loosen
authors.forename: B
authors.initials: B
authors.lastname: Chambliss
authors.forename: N
authors.initials: N
authors.lastname: Ekhator
authors.forename: D
authors.initials: D
authors.lastname: Burns
authors.forename: T D
authors.initials: TD
authors.lastname: Geracioti
authors.forename: D N
authors.initials: DN
authors.lastname: Orth
mesh_terms: D000305:Adrenal Cortex Hormones / Q000097:blood; D000307:Adrenal Gland Diseases / Q000209:etiology / Q000503:physiopathology*; D000328:Adult; D000437:Alcoholism / Q000150:complications*; D003346:Corticotropin-Releasing Hormone; D006801:Humans; D008297:Male; D008875:Middle Aged; D013695:Temperance; D013959:Thyroid Diseases / Q000209:etiology / Q000503:physiopathology*; D013963:Thyroid Hormones / Q000097:blood; D013973:Thyrotropin-Releasing Hormone; D013997:Time Factors
chemical_list: D000305:Adrenal Cortex Hormones; D013963:Thyroid Hormones; D013973:Thyrotropin-Releasing Hormone; D003346:Corticotropin-Releasing Hormone